Wound Care Biologics Market PDF 2019-2024: Global Size, Share, Trends, Analysis & Research Report

1. Global Wound Care Biologics Market Research Report and Forecast 2024 Report Edition: 2019 Copyright © IMARC Service Pvt Ltd. All Rights Reserved © 2019 IMARC All Rights Reserved

2. Report DescriptionAbout IMARC Group The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value challenges, and transform their businesses. opportunities, address their most critical IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Description and Highlights Report Description Global Wound Care Biologics Market Overview: According to the latest report by IMARC Group, titled “Wound Care Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024”, the global wound care biologics market size reached US$ 1.40 Billion in 2018. Wound care biologics refer to drugs derived from, or containing components of, living organisms that help to control or heal infections. Wound care is a complex and intricate process that involves fibrous tissue accretion, wound contraction, coagulatory and inflammatory events, deposition of collagen, tissue granulation and remodeling. Biologic wound care products include active biological agents, such as plant-derived active biomolecules which exhibit antioxidant, antimicrobial, or anti-inflammatory attributes. These biologic wound healing therapies aim to accelerate healing by modulating or augmenting the inflammatory mediators. Global Wound Care Biologics Market Trends Chronic wounds represent a silent epidemic affecting a large proportion of the world’s population. A significant rise in the aging population coupled with the increasing prevalence of chronic skin wounds due to burns and skin cancer has increased these numbers, owing to which, the use of biologics has grown exponentially in recent years to treat or cure infections.

4. Report Description and Highlights Report Description 186.5 181.2 120.2125.5130.8136.1141.4146.7152.0157.3 175.9 170.6 160 180 165.3 160.0 160 140 140 120 In Billion US$ in Billion US$ 120 100 100 80 80 60 60 40 40 20 20 0 0 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Researchers are currently focusing on different approaches of biologic categories in wound healing and the advancements of the individual research tracts that attempt to change wound care from secondary-intent healing and tissue repair to dermal regeneration. Looking forward, the market value is projected to reach US$ 2.35 Billion by 2024, registering a CAGR of around 9% during 2019-2024. Request for a free sample report: https://www.imarcgroup.com/wound-care-biologics- market/requestsample

5. Report Description and Highlights Report Description Also, several companies are offering xenografts that serve as a barrier and protect wounds from bacterial and physical trauma, reduce pain, and increase moisture and heat retention. Significant efforts are also being made to develop cost-effective and high-quality biologics at affordable prices to make them more accessible to patients suffering from acute to chronic wounds worldwide. Moreover, extensive research and development (R&D) are further creating a positive outlook for the market. Key Market Segmentation: Market Segmentation by Product • Biologic Skin Substitutes o Human Donor Tissue-Derived Products o Acellular Animal-Derived Products o Biosynthetic Products Topical Agents • Based on the product, the market has been segmented as biologic skin substitutes (human donor tissue-derived, acellular animal-derived and biosynthetic products) and topical agents.

6. Report Description and Highlights Report Description For more information, click here: https://www.imarcgroup.com/wound-care-biologics-market Market Segmentation by Wound Type • Ulcers o Diabetic Foot Ulcers o Venous Ulcers o Pressure Ulcers o Others Surgical and Traumatic Wounds Burns • • On the basis of the wound type, the market has been segregated into ulcers (diabetic foot, venous, pressure ulcers and others), surgical and traumatic wounds, and burns. Market Segmentation by Application • Acute Wound

7. Report Description and Highlights Report Description • • Chronic Wound Surgical Wound The market has been categorized based on the application into acute, chronic and surgical wounds. Market Segmentation By End-User • • • Hospitals ASCs Burn Centres and Wound Clinics On the basis of the end user, the market has been classified into hospitals, ASCs, and burn centers and wound clinics. Market Segmentation by Region • • Asia Pacific Europe

8. Report Description and Highlights Report Description • • • North America Middle East and Africa Latin America Region-wise, the market has been divided into North America, Asia Pacific, Europe, Middle East and Africa, and Latin America. Competitive Landscape: The competitive landscape of the market has also been examined with some of the key players. • • • • • • • Smith & Nephew Mölnlycke Health Care Integra lifesciences Osiris Therapeutics Avita Medical ConvaTec Group Cytori Therapeutics

9. Report Description and Highlights Report Description • • • • • • • • Mylan Johnson & Johnson Leap Therapeutics Nuo Therapeutics Mallinckrodt Wright Medical Mimedx Group Solsys Medical

10. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

11. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

12. Report Description and Highlights Report Description © 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

13. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com